Abstract: This disclosure relates to a curable composition comprising (a) at least one light polymerizable liquid; (b) at least one epoxy precursor dissolved in component (a); and (c) at least one photoinitiator; wherein the curable composition exhibits no more than 15% increase in viscosity at 25° C. after 7 days at room temperature.

Abstract: The present disclosure relates to a thermoplastic pulverulent composition comprising (a) at least one silica particle treated with alkoxysilane; and (b) at least one thermoplastic polymer. The present disclosure also relates to a 3D-printed object formed from the thermoplastic pulverulent composition and a process of forming the 3D-printed object. The thermoplastic pulverulent composition shows good powder flowability and the printed object obtained from said thermoplastic pulverulent composition surprisingly shows high elongation at break, high impact strength, good toughness and low surface roughness.

Abstract: This disclosure relates to a radiation-curable liquid composition, comprising following components: (A) at least one radiation-curable reactive component; (B) at least one photoinitiator; and (C) at least one expandable microsphere and/or lightweight filler, relates to a 3D-printed object formed from the radiation-curable liquid composition as well as a process of forming the 3D-printed object. The 3D-printed object formed from the composition shows excellent energy return property and good mechanical property as well as low density and foam structure.

Abstract: The present disclosure relates to a pulverulent composition comprising (a) at least one phosphate flame retardant synergist selected from hydrogen phosphate salt, dihydrogen phosphate salt, hydrate thereof and mixture thereof; (b) at least one flame retardant; and (c) at least one thermoplastic polymer. The present disclosure also relates to a 3D-printed object formed from the pulverulent composition and a process of forming 3D-printed object. The pulverulent composition shows good printability and the 3D-printed objects obtained from the thermoplastic powders not only have excellent flame-retardant performance but also have good mechanical properties.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: A system and method for providing video compression that includes encoding using an encoding engine a YUV stream wherein Y, U and V color values are encoded in parallel and patching together the Y, U and V color streams to form a compressed YUV output stream. The encoding engine further includes encoding each color value of the YUV stream in parallel using parallel encoding engines and a control engine for controlling operation all of the encoding engines in parallel. The YUV stream has an average bits per pixel value that varies from a first value to a second value that is double the first value. The encoding engine includes encoding the YUV stream in generally the same amount of time regardless of the average bits per pixel value.

Abstract: A processing apparatus is provided that includes an encoder configured to encode current frames of video data using previously encoded reference frames and perform motion searches within a search window about each of a plurality of co-located portions of a reference frame. The processing apparatus also includes a processor configured to determine, prior to performing the motion searches, which locations of the reference frame to reload the search window according to a threshold number of search window reloads using predicted motions of portions of the reference frame corresponding to each of the locations. The processor is also configured to cause the encoder to reload the search window at the determined locations of the reference frame and, for each of the remaining locations of the reference frame, slide the search window in a first direction indicated by the location of the next co-located portion of the reference frame.

Abstract: Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Oligonucleotide analogs comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: A processing apparatus is provided that includes an encoder configured to encode current frames of video data using previously encoded reference frames and perform motion searches within a search window about each of a plurality of co-located portions of a reference frame. The processing apparatus also includes a processor configured to determine, prior to performing the motion searches, which locations of the reference frame to reload the search window according to a threshold number of search window reloads using predicted motions of portions of the reference frame corresponding to each of the locations. The processor is also configured to cause the encoder to reload the search window at the determined locations of the reference frame and, for each of the remaining locations of the reference frame, slide the search window in a first direction indicated by the location of the next co-located portion of the reference frame.

Abstract: Functionally-modified oligonucleotide analogs comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: A system and method for providing video compression that includes encoding using an encoding engine a YUV stream wherein Y, U and V color values are encoded in parallel and patching together the Y, U and V color streams to form a compressed YUV output stream. The encoding engine further includes encoding each color value of the YUV stream in parallel using parallel encoding engines and a control engine for controlling operation all of the encoding engines in parallel. The YUV stream has an average bits per pixel value that varies from a first value to a second value that is double the first value. The encoding engine includes encoding the YUV stream in generally the same amount of time regardless of the average bits per pixel value.

Abstract: Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Abstract: Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3? and/or 5?-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.